FINANCIAL SUMMARY - FOURTH QUARTER 2020
Henrik Ljung will take the role of Chief Financial Officer, CFO, in Qlife Holding AB.
"Henrik Ljung brings broad experience to Qlife from financial reporting, IR, business control, finance management and corporate governance, all with a focus on fast-growing companies in the early stages. It is with great pleasure that I welcome Henrik to our company," says Thomas Warthoe, CEO of Qlife Holding.
"I look forward to joining Qlife and taking on the role of CFO. Qlife is on an exciting growth journey that is just beginning, and I am personally attracted to companies with a business that contributes to society, which Qlife clearly does through its product range," says Henrik Ljung.
Lars Bangsgaard, who has assumed the role of CFO both in the operating company Qlife ApS in Denmark and in the parent company Qlife Holding AB, will continue in his role as CFO in Qlife ApS.
Henrik Ljung will begin his work with Qlife on July 1, 2020.
“It is of great importance for Qlife to get a significant order from a highly professional customer directly after the CE-marking.
The Danish Patent Office has granted Qlife patent number DK180348 B1 for its biomarker detection unit.
The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market.
Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short.
Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark.
On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for th
”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high preci
Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants